Adjuvant Ipilimumab for Melanoma-The $1.8 Million per Patient Regimen

Daniel A. Goldstein

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)1628-1629
Number of pages2
JournalJAMA Oncology
Volume3
Issue number12
DOIs
StatePublished - 1 Dec 2017
Externally publishedYes

Cite this